{"transactions":[{"id":691890,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-08-11T01:39:05.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":false,"shares":400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 6, 2025, the reporting person was granted 7,200 (400 post-split) RSUs, vesting on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On August 6, 2025, the reporting person was granted 7,200 (400 post-split) RSUs, vesting on the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":400},"source":{"system":"sec-edgar","filing":"0001193125-26-343080","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000119312526343080/ownership.xml","form_type":"4"}},{"id":691889,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-11T01:39:05.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":true,"shares":400,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":400,"source":{"system":"sec-edgar","filing":"0001193125-26-343080","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000119312526343080/ownership.xml","form_type":"4"}},{"id":793585,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-04T21:23:51.000Z","date":"2026-04-30","kind":"grant","planned":false,"acquired":true,"shares":11296,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The number of options granted was determined by multiplying 25% of the total non-employee director compensation value, and then dividing by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":11296,"derivative":{"exercise_price":7.99,"expiration_date":"2033-04-30","underlying":"Common Stock","underlying_shares":11296},"source":{"system":"sec-edgar","filing":"0001380184-26-000005","document":"wk-form4_1777929828.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000138018426000005/wk-form4_1777929828.xml","form_type":"4"}},{"id":793584,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman"}}],"security":"Common Stock","published_at":"2026-05-04T21:23:51.000Z","date":"2026-04-30","kind":"grant","planned":false,"acquired":true,"shares":25344,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual grant of restricted stock units (\"RSUs\") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the \"Company\") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date (\"Annual Grant Vesting Date\"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date."}],"balance_after":149076,"source":{"system":"sec-edgar","filing":"0001380184-26-000005","document":"wk-form4_1777929828.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000138018426000005/wk-form4_1777929828.xml","form_type":"4"}},{"id":1071378,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-08-08T20:27:30.000Z","date":"2025-08-06","kind":"grant","planned":false,"acquired":true,"shares":7200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."}],"balance_after":7200,"derivative":{"underlying":"Common Stock","underlying_shares":7200},"source":{"system":"sec-edgar","filing":"0000950170-25-105887","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025105887/ownership.xml","form_type":"4"}},{"id":1084041,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-07-21T20:43:57.000Z","date":"2025-07-17","kind":"exercise","planned":false,"acquired":false,"shares":1,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On July 17, 2024, the reporting person was granted 925 (1 post-splits) RSUs, vesting in full one year from the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On July 17, 2024, the reporting person was granted 925 (1 post-splits) RSUs, vesting in full one year from the date of grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1},"source":{"system":"sec-edgar","filing":"0000950170-25-097283","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025097283/ownership.xml","form_type":"4"}},{"id":1084040,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-21T20:43:57.000Z","date":"2025-07-17","kind":"exercise","planned":false,"acquired":true,"shares":1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":1,"source":{"system":"sec-edgar","filing":"0000950170-25-097283","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025097283/ownership.xml","form_type":"4"}},{"id":1160822,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-03T00:30:39.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":15824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The number of options granted was determined by multiplying 25% of the total non-employee director compensation value, and then dividing by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":41572,"derivative":{"exercise_price":5.45,"expiration_date":"2032-04-29","underlying":"Common Stock","underlying_shares":15824},"source":{"system":"sec-edgar","filing":"0001367644-25-000105","document":"wk-form4_1746232232.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764425000105/wk-form4_1746232232.xml","form_type":"4"}},{"id":1160821,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman"}}],"security":"Common Stock","published_at":"2025-05-03T00:30:39.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":34403,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual grant of restricted stock units (\"RSUs\") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the \"Company\") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date (\"Annual Grant Vesting Date\"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date."}],"balance_after":123732,"source":{"system":"sec-edgar","filing":"0001367644-25-000105","document":"wk-form4_1746232232.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764425000105/wk-form4_1746232232.xml","form_type":"4"}},{"id":1451204,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-07-19T20:38:17.000Z","date":"2024-07-17","kind":"grant","planned":false,"acquired":true,"shares":925,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."}],"balance_after":925,"derivative":{"underlying":"Common Stock","underlying_shares":925},"source":{"system":"sec-edgar","filing":"0000950170-24-084958","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024084958/ownership.xml","form_type":"4"}},{"id":1495162,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-06-03T20:58:47.000Z","date":"2024-06-02","kind":"exercise","planned":false,"acquired":false,"shares":81,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On June 2, 2023, the reporting person was granted 3,571 (81 post-split) RSUs, vesting in full on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On June 2, 2023, the reporting person was granted 3,571 (81 post-split) RSUs, vesting in full on the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":81},"source":{"system":"sec-edgar","filing":"0000950170-24-068073","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024068073/ownership.xml","form_type":"4"}},{"id":1495161,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-06-03T20:58:47.000Z","date":"2024-06-01","kind":"exercise","planned":false,"acquired":false,"shares":7,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 1, 2021, the reporting person was granted 893 (20 post-split) RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 1, 2021, the reporting person was granted 893 (20 post-split) RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7},"source":{"system":"sec-edgar","filing":"0000950170-24-068073","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024068073/ownership.xml","form_type":"4"}},{"id":1495160,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-03T20:58:47.000Z","date":"2024-06-02","kind":"exercise","planned":false,"acquired":true,"shares":81,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On March 5, 2024, the Issuer effected a 1-for-44 reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split."}],"balance_after":280,"source":{"system":"sec-edgar","filing":"0000950170-24-068073","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024068073/ownership.xml","form_type":"4"}},{"id":1495159,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-03T20:58:47.000Z","date":"2024-06-01","kind":"exercise","planned":false,"acquired":true,"shares":7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On March 5, 2024, the Issuer effected a 1-for-44 reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split."}],"balance_after":199,"source":{"system":"sec-edgar","filing":"0000950170-24-068073","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024068073/ownership.xml","form_type":"4"}},{"id":1500057,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-29T01:14:42.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":25748,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The number of options granted was determined by dividing half of the total non-employee director compensation value by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":25748,"derivative":{"exercise_price":5.02,"expiration_date":"2031-05-22","underlying":"Common Stock","underlying_shares":25748},"source":{"system":"sec-edgar","filing":"0001367644-24-000078","document":"wk-form4_1716945275.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764424000078/wk-form4_1716945275.xml","form_type":"4"}},{"id":1500056,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman"}}],"security":"Common Stock","published_at":"2024-05-29T01:14:42.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":17430,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual grant of restricted stock units (\"RSUs\") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the \"Company\") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date (\"Annual Grant Vesting Date\"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date."}],"balance_after":89329,"source":{"system":"sec-edgar","filing":"0001367644-24-000078","document":"wk-form4_1716945275.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764424000078/wk-form4_1716945275.xml","form_type":"4"}},{"id":1810874,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-08-10T20:08:57.000Z","date":"2023-08-09","kind":"exercise","planned":false,"acquired":false,"shares":3571,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 9, 2022, the reporting person was granted 3,571 RSUs, vesting in full on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On August 9, 2022, the reporting person was granted 3,571 RSUs, vesting in full on the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3571},"source":{"system":"sec-edgar","filing":"0001209191-23-045301","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000120919123045301/doc4.xml","form_type":"4"}},{"id":1810873,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-10T20:08:57.000Z","date":"2023-08-09","kind":"exercise","planned":false,"acquired":true,"shares":3571,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":8475,"source":{"system":"sec-edgar","filing":"0001209191-23-045301","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000120919123045301/doc4.xml","form_type":"4"}},{"id":1869918,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-06-02T20:41:10.000Z","date":"2023-06-02","kind":"grant","planned":false,"acquired":true,"shares":3571,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in full on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in full on the first anniversary of the date of grant."}],"balance_after":3571,"derivative":{"underlying":"Common Stock","underlying_shares":3571},"source":{"system":"sec-edgar","filing":"0001209191-23-033828","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000120919123033828/doc4.xml","form_type":"4"}},{"id":1869917,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-06-02T20:41:10.000Z","date":"2023-06-01","kind":"exercise","planned":false,"acquired":false,"shares":297,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On June 1, 2021, the reporting person was granted 893 RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On June 1, 2021, the reporting person was granted 893 RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022."}],"balance_after":298,"derivative":{"underlying":"Common Stock","underlying_shares":297},"source":{"system":"sec-edgar","filing":"0001209191-23-033828","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000120919123033828/doc4.xml","form_type":"4"}},{"id":1869916,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-02T20:41:10.000Z","date":"2023-06-01","kind":"exercise","planned":false,"acquired":true,"shares":297,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":4904,"source":{"system":"sec-edgar","filing":"0001209191-23-033828","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000120919123033828/doc4.xml","form_type":"4"}},{"id":1874422,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman"}}],"security":"Common Stock","published_at":"2023-05-30T23:04:40.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":33847,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted under the company's Stock Incentive Plan, as amended and restated. These restricted stock units vest in one installment beginning on the day prior to the first anniversary of the date of grant assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":71899,"source":{"system":"sec-edgar","filing":"0001367644-23-000104","document":"wk-form4_1685487864.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764423000104/wk-form4_1685487864.xml","form_type":"4"}},{"id":2189420,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-08-10T20:07:38.000Z","date":"2022-08-09","kind":"grant","acquired":true,"shares":3571,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."}],"balance_after":3571,"derivative":{"underlying":"Common Stock","underlying_shares":3571},"source":{"system":"sec-edgar","filing":"0001209191-22-045182","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000120919122045182/doc4.xml","form_type":"4"}},{"id":2244760,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-06-03T19:10:12.000Z","date":"2022-06-01","kind":"exercise","acquired":false,"shares":298,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 1, 2021, the reporting person was granted 893 RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 1, 2021, the reporting person was granted 893 RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022."}],"balance_after":595,"derivative":{"underlying":"Common Stock","underlying_shares":298},"source":{"system":"sec-edgar","filing":"0001209191-22-033930","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000120919122033930/doc4.xml","form_type":"4"}},{"id":2244759,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-03T19:10:12.000Z","date":"2022-06-01","kind":"exercise","acquired":true,"shares":298,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares beneficially owned by the reporting person were adjusted to include the following shares of the Issuer's common stock: (i) 210 shares that were inadvertently omitted from the Form 4 filed on August 5, 2016; and (ii) 527 shares that were originally disclosed in the Form 4 filed on August 5, 2016, but due to a mathematical error, were not included in the aggregate number of shares beneficially owned in the Form 4 filed on June 7, 2019. In each of subsections (i) and (ii) above, the number of shares were adjusted to reflect a 1-for-14 reverse stock split of the Issuer's common stock effective as of March 26, 2020."}],"balance_after":4607,"source":{"system":"sec-edgar","filing":"0001209191-22-033930","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000120919122033930/doc4.xml","form_type":"4"}},{"id":2250990,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-31T20:24:53.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":8446,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated."},{"field":"shares","element":"transactionShares","label":"F2","text":"These restricted stock units vest in three equal annual installments beginning on the earlier of: (i) the day prior to the first anniversary of the date of grant, or (ii) the day prior to annual shareholder meeting; assuming continued service with the company."}],"balance_after":38052,"source":{"system":"sec-edgar","filing":"0001367644-22-000094","document":"wf-form4_165402866909554.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764422000094/wf-form4_165402866909554.xml","form_type":"4"}},{"id":2686616,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2021-06-02T23:34:11.000Z","date":"2021-06-01","kind":"grant","acquired":true,"shares":893,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted stock units (the \"RSUs\") convert into shares of the Issuer's common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in three approximately equal annual installments beginning on June 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in three approximately equal annual installments beginning on June 1, 2022."}],"balance_after":893,"derivative":{"underlying":"Common Stock","underlying_shares":893},"source":{"system":"sec-edgar","filing":"0001019056-21-000357","document":"harsanyi.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905621000357/harsanyi.xml","form_type":"4"}},{"id":2686615,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-02T23:34:11.000Z","date":"2021-06-01","kind":"grant","acquired":true,"shares":2678,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in three approximately equal annual installments beginning on June 1, 2022."}],"balance_after":2678,"derivative":{"exercise_price":26.15,"expiration_date":"2031-06-01","underlying":"Common Stock","underlying_shares":2678},"source":{"system":"sec-edgar","filing":"0001019056-21-000357","document":"harsanyi.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905621000357/harsanyi.xml","form_type":"4"}},{"id":2698372,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-24T21:08:30.000Z","date":"2021-05-20","kind":"grant","acquired":true,"shares":5027,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated."},{"field":"shares","element":"transactionShares","label":"F2","text":"These restricted stock units vest in three equal annual installments beginning on the earlier of: (i) the day prior to the first anniversary of the date of grant, or (ii) the day prior to annual shareholder meeting; assuming continued service with the company."}],"balance_after":29606,"source":{"system":"sec-edgar","filing":"0001367644-21-000093","document":"wf-form4_162189049034879.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764421000093/wf-form4_162189049034879.xml","form_type":"4"}},{"id":2854811,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-02-18T02:01:33.000Z","date":"2020-07-02","kind":"grant","acquired":true,"shares":3571,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in three approximately equal annual installments beginning on July 2, 2021."}],"balance_after":3571,"derivative":{"exercise_price":9.18,"expiration_date":"2030-07-02","underlying":"Common Stock","underlying_shares":3571},"source":{"system":"sec-edgar","filing":"0001019056-21-000143","document":"harsanyi.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905621000143/harsanyi.xml","form_type":"4"}},{"id":3053651,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-18T13:12:22.000Z","date":"2020-08-17","kind":"sale","acquired":false,"shares":6609,"price":133.7062,"value":883664.2758,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $133.22 to $134.11."}],"balance_after":24579,"source":{"system":"sec-edgar","filing":"0001367644-20-000136","document":"wf-form4_159775632755761.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000136/wf-form4_159775632755761.xml","form_type":"4"}},{"id":3074069,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-07-31T20:50:35.000Z","date":"2020-07-27","kind":"grant","acquired":true,"shares":170,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"These options will vest in three approximately equal annual installments beginning on the one year anniversary of the date of grant."}],"balance_after":170,"derivative":{"exercise_price":8.56,"expiration_date":"2030-07-26","underlying":"Common Stock","underlying_shares":170},"source":{"system":"sec-edgar","filing":"0001019056-20-000452","document":"harsanyi.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905620000452/harsanyi.xml","form_type":"4"}},{"id":3074068,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-07-31T20:50:35.000Z","date":"2020-07-27","kind":"grant","acquired":true,"shares":1322,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These options vest in full on the one year anniversary of the date of grant."}],"balance_after":1322,"derivative":{"exercise_price":8.56,"expiration_date":"2030-07-26","underlying":"Common Stock","underlying_shares":1322},"source":{"system":"sec-edgar","filing":"0001019056-20-000452","document":"harsanyi.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905620000452/harsanyi.xml","form_type":"4"}},{"id":3074067,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-07-31T20:50:35.000Z","date":"2020-07-27","kind":"disposition_to_issuer","acquired":false,"shares":1785,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These options provide for vesting in three approximately equal annual installments beginning on May 31, 2019. Prior to July 27, 2020, all but 595 shares of the issuer's common stock underlying this stock option had vested."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."}],"balance_after":0,"derivative":{"exercise_price":76.86,"expiration_date":"2028-06-01","underlying":"Common Stock","underlying_shares":1785},"source":{"system":"sec-edgar","filing":"0001019056-20-000452","document":"harsanyi.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905620000452/harsanyi.xml","form_type":"4"}},{"id":3074066,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-07-31T20:50:35.000Z","date":"2020-07-27","kind":"disposition_to_issuer","acquired":false,"shares":892,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options vested in three approximately equal annual installments beginning on June 1, 2018."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."}],"balance_after":0,"derivative":{"exercise_price":30.1,"expiration_date":"2027-06-01","underlying":"Common Stock","underlying_shares":892},"source":{"system":"sec-edgar","filing":"0001019056-20-000452","document":"harsanyi.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905620000452/harsanyi.xml","form_type":"4"}},{"id":3074065,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-07-31T20:50:35.000Z","date":"2020-07-27","kind":"disposition_to_issuer","acquired":false,"shares":1339,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options vested in three approximately equal annual installments beginning on August 3, 2017."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."}],"balance_after":0,"derivative":{"exercise_price":41.16,"expiration_date":"2026-08-03","underlying":"Common Stock","underlying_shares":1339},"source":{"system":"sec-edgar","filing":"0001019056-20-000452","document":"harsanyi.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905620000452/harsanyi.xml","form_type":"4"}},{"id":3134812,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-26T12:38:43.000Z","date":"2020-05-21","kind":"grant","acquired":true,"shares":2821,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated."},{"field":"shares","element":"transactionShares","label":"F2","text":"These restricted stock units vest in three equal annual installments beginning on the earlier of: (i) the day prior to the first anniversary of the date of grant, or (ii) the day prior to annual shareholder meeting; assuming continued service with the company."}],"balance_after":31188,"source":{"system":"sec-edgar","filing":"0001367644-20-000072","document":"wf-form4_159049670609196.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000072/wf-form4_159049670609196.xml","form_type":"4"}},{"id":3145065,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2020-05-18T23:12:48.000Z","date":"2020-05-14","kind":"exercise","acquired":false,"shares":3434,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of an option granted under the company's stock incentive plan as amended and restated."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests in three equal installments beginning on the anniversary date of the grant, 5/22/2014."}],"balance_after":0,"derivative":{"exercise_price":18.64,"expiration_date":"2021-05-22","underlying":"Common Stock","underlying_shares":3434},"source":{"system":"sec-edgar","filing":"0001367644-20-000068","document":"wf-form4_158984355155712.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000068/wf-form4_158984355155712.xml","form_type":"4"}},{"id":3145064,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-18T23:12:48.000Z","date":"2020-05-14","kind":"exercise","acquired":true,"shares":3434,"price":18.64,"value":64009.76,"ownership":{"direct":true},"balance_after":28367,"source":{"system":"sec-edgar","filing":"0001367644-20-000068","document":"wf-form4_158984355155712.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000068/wf-form4_158984355155712.xml","form_type":"4"}},{"id":3150362,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-13T23:47:30.000Z","date":"2020-05-11","kind":"sale","acquired":false,"shares":4940,"price":81.9888,"value":405024.672,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.5100 to $82.4150, inclusive."}],"balance_after":24933,"source":{"system":"sec-edgar","filing":"0001367644-20-000063","document":"wf-form4_158941363023581.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000063/wf-form4_158941363023581.xml","form_type":"4"}},{"id":3204489,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-17T20:39:22.000Z","date":"2020-03-16","kind":"sale","acquired":false,"shares":6400,"price":65,"value":416000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated."}],"balance_after":29873,"source":{"system":"sec-edgar","filing":"0001367644-20-000031","document":"wf-form4_158447754462323.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000031/wf-form4_158447754462323.xml","form_type":"4"}},{"id":3307472,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-17T21:19:32.000Z","date":"2020-01-16","kind":"sale","acquired":false,"shares":3435,"price":55,"value":188925.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted the Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended."},{"field":"shares","element":"transactionShares","label":"F2","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Harsanyi."}],"balance_after":36273,"source":{"system":"sec-edgar","filing":"0001367644-20-000004","document":"wf-form4_157929595097570.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000004/wf-form4_157929595097570.xml","form_type":"4"}},{"id":3497263,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false,"officer_title":"Board of Directors"}}],"security":"Common Stock","published_at":"2019-06-07T19:19:22.000Z","date":"2019-06-07","kind":"purchase","acquired":true,"shares":50000,"price":0.78,"value":39000.0,"ownership":{"direct":true},"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001593968-19-001344","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000159396819001344/primary_01.xml","form_type":"4"}},{"id":3502514,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false,"officer_title":"Board of Directors"}}],"security":"Option (right to buy)","published_at":"2019-06-04T17:01:14.000Z","date":"2019-06-01","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option was granted on June 1, 2019 and becomes exercisable in three equal annual installments beginning on June 1, 2020."}],"balance_after":25000,"derivative":{"exercise_price":0.725,"exercise_date":"2020-06-01","expiration_date":"2029-06-01","underlying":"Aptevo Therapeutics Inc. common stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001593968-19-001277","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000159396819001277/primary_01.xml","form_type":"4"}},{"id":3509954,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-29T00:10:23.000Z","date":"2019-05-23","kind":"grant","acquired":true,"shares":5736,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"These restricted stock units vest in three equal annual installments beginning on the earlier of: (i) the day prior to the first anniversary of the date of grant, or (ii) the day prior to annual shareholder meeting; assuming continued service with the company."}],"balance_after":39708,"source":{"system":"sec-edgar","filing":"0001567619-19-012274","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761919012274/doc1.xml","form_type":"4"}},{"id":3770379,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-08T21:34:27.000Z","date":"2018-11-06","kind":"sale","acquired":false,"shares":8000,"price":68.8992,"value":551193.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.34 to $69.27, inclusive."}],"balance_after":33972,"source":{"system":"sec-edgar","filing":"0001567619-18-005431","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761918005431/doc1.xml","form_type":"4"}},{"id":3908534,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-04T22:53:53.000Z","date":"2018-06-01","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in three equal annual installments beginning on May 31, 2019."}],"balance_after":25000,"derivative":{"exercise_price":5.49,"expiration_date":"2028-05-31","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001019056-18-000784","document":"harsanyi_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905618000784/harsanyi_4.xml","form_type":"4"}},{"id":3918267,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-24T22:29:19.000Z","date":"2018-05-24","kind":"grant","acquired":true,"shares":4895,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Fourth Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended."},{"field":"shares","element":"transactionShares","label":"F2","text":"These restricted stock units vest in three equal annual installments beginning on the earlier of (i) the day prior to the anniversary of the date of grant or (ii) one business day prior to date of the Company's next annual meeting; provided that the individual is serving on the Board on such date."}],"balance_after":41972,"source":{"system":"sec-edgar","filing":"0001140361-18-025560","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036118025560/doc1.xml","form_type":"4"}},{"id":4136121,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-12-11T13:25:15.000Z","date":"2017-12-07","kind":"sale","acquired":false,"shares":7000,"price":42.47,"value":297290.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of vested restricted stock units granted under the Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended and restated."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.35 to $42.59, inclusive."}],"balance_after":37077,"source":{"system":"sec-edgar","filing":"0001140361-17-045556","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117045556/doc1.xml","form_type":"4"}},{"id":4298213,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-06-02T01:38:46.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in three equal annual installments beginning on June 1, 2018."}],"balance_after":12500,"derivative":{"exercise_price":2.15,"expiration_date":"2027-05-31","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001019056-17-000545","document":"harsanyi_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905617000545/harsanyi_4.xml","form_type":"4"}},{"id":4302647,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to buy)","published_at":"2017-05-26T18:18:25.000Z","date":"2016-08-01","kind":"other","acquired":true,"shares":301,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"Consists of an option granted on May 22, 2014 under the company's stock incentive plan as amended and restated.  In connection with the spin-off on August 1, 2016, the reporting person received a grant of additional stock options as a result of an adjustment to preserve the pre-spin intrinsic value of an existing stock option grant.  The adjustments included an adjustment to the stock option price of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"In connection with the spin-off (the \"Spin-off\") of Aptevo Therapeutics Inc. from Emergent BioSolutions Inc. (\"Emergent\"), on August 1, 2016 the reporting person received a grant of stock options as a result of an adjustment to an existing Emergent stock option grant held by the reporting person prior to the Spin-off.  The stock options vest in May 2017."}],"balance_after":3434,"derivative":{"exercise_price":18.64,"expiration_date":"2021-05-21","underlying":"Common Stock","underlying_shares":3434},"source":{"system":"sec-edgar","filing":"0001140361-17-022490","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117022490/doc1.xml","form_type":"4"}},{"id":4302646,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-26T18:18:25.000Z","date":"2017-05-25","kind":"grant","acquired":true,"shares":8259,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Consists of restricted stock units granted under the Fourth Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan."},{"field":"shares","element":"transactionShares","label":"F5","text":"These restricted stock units vest in three equal annual installments beginning on the earlier of (i) the anniversary of the date of grant or (ii) one business day prior to date of the Company's next annual meeting; provided that the individual is serving on the Board on such date."}],"balance_after":44077,"source":{"system":"sec-edgar","filing":"0001140361-17-022490","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117022490/doc1.xml","form_type":"4"}},{"id":4302645,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-26T18:18:25.000Z","date":"2016-08-01","kind":"other","acquired":true,"shares":577,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"In connection with the spin-off of Aptevo Therapeutics Inc. from Emergent BioSolutions Inc, on August 1, 2016 the reporting person received a grant of restricted stock units as a result of an adjustment to an existing Emergent restricted stock unit grant held by the reporting person prior to the spin-off. The restricted stock units vest in May 2017, May 2018 and May 2019."}],"balance_after":35818,"source":{"system":"sec-edgar","filing":"0001140361-17-022490","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117022490/doc1.xml","form_type":"4"}},{"id":4302644,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-26T18:18:25.000Z","date":"2016-08-01","kind":"other","acquired":true,"shares":604,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"In connection with the spin-off of Aptevo Therapeutics Inc. from Emergent BioSolutions Inc, on August 1, 2016 the reporting person received a grant of restricted stock units as a result of an adjustment to an existing Emergent restricted stock unit grant held by the reporting person prior to the spin-off. The restricted stock units vest in  May 2017 and May 2018."}],"balance_after":35241,"source":{"system":"sec-edgar","filing":"0001140361-17-022490","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117022490/doc1.xml","form_type":"4"}},{"id":4302643,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25019,"kind":"person","name":"Harsanyi Zsolt","position":1,"cik":"0001380184","reported_name":"Harsanyi Zsolt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-26T18:18:25.000Z","date":"2016-08-01","kind":"other","acquired":true,"shares":152,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"In connection with the spin-off of Aptevo Therapeutics Inc. from Emergent BioSolutions Inc, on August 1, 2016 the reporting person received a grant of restricted stock units as a result of an adjustment to an existing Emergent restricted stock unit grant held by the reporting person prior to the spin-off. The restricted stock units vest in May 2017."}],"balance_after":34637,"source":{"system":"sec-edgar","filing":"0001140361-17-022490","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117022490/doc1.xml","form_type":"4"}}]}